Ownership history in Clearline Capital LP · 7 quarters on record
This page tracks every 13F SEC filing in which Clearline Capital LP reported a position in GLOBUS MED INC (GMED). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 148,472 | +114,917 | +342.5% | 0.39% | $8.5M | $57.27 |
| 2025 Q2 | REDUCED | 33,555 | -30,222 | -47.4% | 0.07% | $2.0M | $59.02 |
| 2024 Q3 | REDUCED | 63,777 | -251,192 | -79.8% | 0.19% | $4.6M | $71.54 |
| 2024 Q2 | REDUCED | 314,969 | -166,635 | -34.6% | 0.60% | $21.6M | $68.49 |
As of 2025 Q4 — sorted by position size